Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
SITAGLIPTIN PHOSPHATE
(2006)
Small molecule
Dipeptidyl peptidase IV inhibitor
ORAL
Approved
Diabetes Mellitus, Type 2; Hyperlipidemias; Myocardial Infarction; Stroke
SITAGLIPTIN PHOSPHATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
TS63EW8X6F
Molecule Type:
Small molecule
Molecular Formula:
C16H20F6N5O6P
Molecular Weight:
523.33
AlogP:
2.02
PSA:
77.04
HBD:
1.0
HBA:
#RotB:
4.0
Source:
DARUNAVIR ETHANOLATE
(2006)
Small molecule
Human immunodeficiency virus type 1 protease inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections; Infections
DARUNAVIR ETHANOLATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
33O78XF0BW
Molecule Type:
Small molecule
Molecular Formula:
C29H43N3O8S
Molecular Weight:
593.74
AlogP:
2.38
PSA:
140.42
HBD:
3.0
HBA:
#RotB:
11.0
Source:
DASATINIB
(2006)
Small molecule
Bcr/Abl fusion protein
ORAL
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
DASATINIB
×
Maximum Phase:
4
First Approval:
2006
UNII:
RBZ1571X5H
Molecule Type:
Small molecule
Molecular Formula:
C22H26ClN7O2S
Molecular Weight:
488.02
AlogP:
3.31
PSA:
106.51
HBD:
3.0
HBA:
#RotB:
7.0
Source:
RANOLAZINE
(2006)
Small molecule
Sodium channel protein type IV alpha subunit blocker
ORAL
Approved
Angina Pectoris; Cardiovascular Diseases
RANOLAZINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
A6IEZ5M406
Molecule Type:
Small molecule
Molecular Formula:
C24H33N3O4
Molecular Weight:
427.55
AlogP:
2.31
PSA:
74.27
HBD:
2.0
HBA:
#RotB:
9.0
Source:
ECAMSULE
(2006)
Small molecule
Sunscreen
Unknown
Approved
Unknown
ECAMSULE
×
Maximum Phase:
4
First Approval:
2006
UNII:
M94R1PM439
Molecule Type:
Small molecule
Molecular Formula:
C28H34O8S2
Molecular Weight:
562.71
AlogP:
4.24
PSA:
142.88
HBD:
2.0
HBA:
#RotB:
6.0
Source:
OCTOCRYLENE
(2006)
Small molecule
Sunscreen
Unknown
Approved
Melanosis
OCTOCRYLENE
×
Maximum Phase:
4
First Approval:
2006
UNII:
5A68WGF6WM
Molecule Type:
Small molecule
Molecular Formula:
C24H27NO2
Molecular Weight:
361.49
AlogP:
5.77
PSA:
50.09
HBD:
0.0
HBA:
#RotB:
9.0
Source:
FENTANYL HYDROCHLORIDE
(2006)
Small molecule
Mu opioid receptor agonist
IONTOPHORESIS; TRANSDERMAL
Approved
Unknown
FENTANYL HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2006
UNII:
59H156XY46
Molecule Type:
Small molecule
Molecular Formula:
C22H29ClN2O
Molecular Weight:
372.94
AlogP:
4.14
PSA:
23.55
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RIMONABANT
(2006)
Small molecule
Cannabinoid CB1 receptor antagonist
Unknown
Approved
Obesity
RIMONABANT
×
Maximum Phase:
4
First Approval:
2006
UNII:
RML78EN3XE
Molecule Type:
Small molecule
Molecular Formula:
C22H21Cl3N4O
Molecular Weight:
463.8
AlogP:
5.94
PSA:
50.16
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SITAGLIPTIN
(2006)
Small molecule
Unknown
Unknown
Approved
Diabetes Mellitus
SITAGLIPTIN
×
Maximum Phase:
4
First Approval:
2006
UNII:
QFP0P1DV7Z
Molecule Type:
Small molecule
Molecular Formula:
C16H15F6N5O
Molecular Weight:
407.32
AlogP:
2.02
PSA:
77.04
HBD:
1.0
HBA:
#RotB:
4.0
Source:
BISMUTH SUBCITRATE POTASSIUM
(2006)
Small molecule
Unknown
Unknown
Approved
Unknown
BISMUTH SUBCITRATE POTASSIUM
×
Maximum Phase:
4
First Approval:
2006
UNII:
R3O80H60KX
Molecule Type:
Small molecule
Molecular Formula:
C12H10BiK3O14
Molecular Weight:
704.47
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
VARENICLINE TARTRATE
(2006)
Small molecule
Neuronal acetylcholine receptor; alpha4/beta2 agonist
ORAL
Approved
Unknown
VARENICLINE TARTRATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
82269ASB48
Molecule Type:
Small molecule
Molecular Formula:
C17H19N3O6
Molecular Weight:
361.35
AlogP:
1.8
PSA:
37.81
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SITAXENTAN
(2006)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
Unknown
Approved
Hypertension
SITAXENTAN
×
Maximum Phase:
4
First Approval:
2006
UNII:
J9QH779MEM
Molecule Type:
Small molecule
Molecular Formula:
C18H15ClN2O6S2
Molecular Weight:
454.91
AlogP:
3.96
PSA:
107.73
HBD:
1.0
HBA:
#RotB:
6.0
Source:
ARFORMOTEROL TARTRATE
(2006)
Small molecule
Beta-2 adrenergic receptor agonist
INHALATION
Approved
Bronchitis, Chronic; Emphysema; Pulmonary Disease, Chronic Obstructive
ARFORMOTEROL TARTRATE
×
Maximum Phase:
4
First Approval:
2006
UNII:
5P8VJ2I235
Molecule Type:
Small molecule
Molecular Formula:
C23H30N2O10
Molecular Weight:
494.5
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
ARFORMOTEROL
(2006)
Small molecule
Unknown
Unknown
Approved
Unknown
ARFORMOTEROL
×
Maximum Phase:
4
First Approval:
2006
UNII:
F91H02EBWT
Molecule Type:
Small molecule
Molecular Formula:
C19H24N2O4
Molecular Weight:
344.41
AlogP:
2.22
PSA:
90.82
HBD:
4.0
HBA:
#RotB:
9.0
Source:
RASAGILINE
(2006)
Small molecule
Unknown
ORAL
Approved
Parkinson Disease
RASAGILINE
×
Maximum Phase:
4
First Approval:
2006
UNII:
003N66TS6T
Molecule Type:
Small molecule
Molecular Formula:
C12H13N
Molecular Weight:
171.24
AlogP:
1.9
PSA:
12.03
HBD:
1.0
HBA:
#RotB:
2.0
Source:
PALIPERIDONE
(2006)
Small molecule
Dopamine D2 receptor antagonist
ORAL
Approved
Psychotic Disorders; Schizophrenia
PALIPERIDONE
×
Maximum Phase:
4
First Approval:
2006
UNII:
838F01T721
Molecule Type:
Small molecule
Molecular Formula:
C23H27FN4O3
Molecular Weight:
426.49
AlogP:
3.08
PSA:
84.39
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SAPROPTERIN
(2007)
Small molecule
Unknown
Unknown
Approved
Unknown
SAPROPTERIN
×
Maximum Phase:
4
First Approval:
2007
UNII:
EGX657432I
Molecule Type:
Small molecule
Molecular Formula:
C9H15N5O3
Molecular Weight:
241.25
AlogP:
-1.29
PSA:
136.55
HBD:
6.0
HBA:
#RotB:
2.0
Source:
NEBIVOLOL
(2007)
Small molecule
Unknown
Unknown
Approved
Cardiovascular Diseases
NEBIVOLOL
×
Maximum Phase:
4
First Approval:
2007
UNII:
030Y90569U
Molecule Type:
Small molecule
Molecular Formula:
C22H25F2NO4
Molecular Weight:
405.44
AlogP:
2.36
PSA:
70.95
HBD:
3.0
HBA:
#RotB:
6.0
Source:
NILOTINIB
(2007)
Small molecule
Unknown
Unknown
Approved
Neoplasms
NILOTINIB
×
Maximum Phase:
4
First Approval:
2007
UNII:
F41401512X
Molecule Type:
Small molecule
Molecular Formula:
C28H22F3N7O
Molecular Weight:
529.53
AlogP:
6.36
PSA:
97.62
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ALISKIREN FUMARATE
(2007)
Small molecule
Renin inhibitor
Unknown
Approved
Hypertension; Stroke
ALISKIREN FUMARATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
C8A0P8G029
Molecule Type:
Small molecule
Molecular Formula:
C64H110N6O16
Molecular Weight:
1219.61
AlogP:
3.29
PSA:
146.13
HBD:
4.0
HBA:
#RotB:
19.0
Source:
LISDEXAMFETAMINE DIMESYLATE
(2007)
Small molecule
Dopamine transporter releasing agent
ORAL
Approved
Arteriosclerosis; Attention Deficit Disorder with Hyperactivity; Binge-Eating Disorder; Glaucoma; Substance-Related Disorders
LISDEXAMFETAMINE DIMESYLATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
SJT761GEGS
Molecule Type:
Small molecule
Molecular Formula:
C17H33N3O7S2
Molecular Weight:
455.6
AlogP:
1.19
PSA:
81.14
HBD:
3.0
HBA:
#RotB:
8.0
Source:
MARAVIROC
(2007)
Small molecule
C-C chemokine receptor type 5 antagonist
ORAL
Approved
Autoimmune Diseases; HIV Infections; Virus Diseases
MARAVIROC
×
Maximum Phase:
4
First Approval:
2007
UNII:
MD6P741W8A
Molecule Type:
Small molecule
Molecular Formula:
C29H41F2N5O
Molecular Weight:
513.68
AlogP:
5.95
PSA:
63.05
HBD:
1.0
HBA:
#RotB:
8.0
Source:
RALTEGRAVIR POTASSIUM
(2007)
Small molecule
Human immunodeficiency virus type 1 integrase inhibitor
ORAL
Approved
Autoimmune Diseases; HIV Infections
RALTEGRAVIR POTASSIUM
×
Maximum Phase:
4
First Approval:
2007
UNII:
43Y000U234
Molecule Type:
Small molecule
Molecular Formula:
C20H20FKN6O5
Molecular Weight:
482.51
AlogP:
0.91
PSA:
152.24
HBD:
3.0
HBA:
#RotB:
6.0
Source:
SEVELAMER
(2007)
Small molecule
Unknown
Unknown
Approved
Unknown
SEVELAMER
×
Maximum Phase:
4
First Approval:
2007
UNII:
941N5DUU5C
Molecule Type:
Small molecule
Molecular Formula:
C6H12ClNO
Molecular Weight:
149.62
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AMBRISENTAN
(2007)
Small molecule
Endothelin receptor, ET-A/ET-B antagonist
ORAL
Approved
Familial Primary Pulmonary Hypertension; Hypertension; Hypertension, Pulmonary; Pulmonary Arterial Hypertension
AMBRISENTAN
×
Maximum Phase:
4
First Approval:
2007
UNII:
HW6NV07QEC
Molecule Type:
Small molecule
Molecular Formula:
C22H22N2O4
Molecular Weight:
378.43
AlogP:
3.52
PSA:
81.54
HBD:
1.0
HBA:
#RotB:
7.0
Source:
IXABEPILONE
(2007)
Small molecule
Tubulin inhibitor
INTRAVENOUS
Approved
Breast Neoplasms; Neoplasms
IXABEPILONE
×
Maximum Phase:
4
First Approval:
2007
UNII:
K27005NP0A
Molecule Type:
Small molecule
Molecular Formula:
C27H42N2O5S
Molecular Weight:
506.71
AlogP:
4.05
PSA:
112.05
HBD:
3.0
HBA:
#RotB:
2.0
Source:
FLUTICASONE FUROATE
(2007)
Small molecule
Glucocorticoid receptor agonist
INHALATION; NASAL
Approved
Asthma; Lung Diseases, Obstructive; Nasal Obstruction; Pulmonary Disease, Chronic Obstructive; Rhinitis, Allergic, Perennial; Rhinitis, Allergic, Seasonal
FLUTICASONE FUROATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
JS86977WNV
Molecule Type:
Small molecule
Molecular Formula:
C27H29F3O6S
Molecular Weight:
538.58
AlogP:
4.93
PSA:
93.81
HBD:
1.0
HBA:
#RotB:
4.0
Source:
SAPROPTERIN DIHYDROCHLORIDE
(2007)
Small molecule
Phenylalanine-4-hydroxylase activator
ORAL; UNKNOWN
Approved
Phenylketonurias
SAPROPTERIN DIHYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
2007
UNII:
RG277LF5B3
Molecule Type:
Small molecule
Molecular Formula:
C9H17Cl2N5O3
Molecular Weight:
314.17
AlogP:
-1.29
PSA:
136.55
HBD:
6.0
HBA:
#RotB:
2.0
Source:
NILOTINIB HYDROCHLORIDE MONOHYDRATE
(2007)
Small molecule
Bcr/Abl fusion protein
Unknown
Approved
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
NILOTINIB HYDROCHLORIDE MONOHYDRATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
5JHU0N1R6K
Molecule Type:
Small molecule
Molecular Formula:
C28H25ClF3N7O2
Molecular Weight:
584.0
AlogP:
6.36
PSA:
97.62
HBD:
2.0
HBA:
#RotB:
6.0
Source:
LAPATINIB
(2007)
Small molecule
Unknown
ORAL
Approved
Neoplasms
LAPATINIB
×
Maximum Phase:
4
First Approval:
2007
UNII:
0VUA21238F
Molecule Type:
Small molecule
Molecular Formula:
C29H26ClFN4O4S
Molecular Weight:
581.07
AlogP:
6.14
PSA:
106.35
HBD:
2.0
HBA:
#RotB:
11.0
Source:
LISDEXAMFETAMINE
(2007)
Small molecule
Unknown
Unknown
Approved
Attention Deficit Disorder with Hyperactivity
LISDEXAMFETAMINE
×
Maximum Phase:
4
First Approval:
2007
UNII:
H645GUL8KJ
Molecule Type:
Small molecule
Molecular Formula:
C15H25N3O
Molecular Weight:
263.38
AlogP:
1.19
PSA:
81.14
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RETAPAMULIN
(2007)
Small molecule
70S ribosome inhibitor
Unknown
Approved
Impetigo
RETAPAMULIN
×
Maximum Phase:
4
First Approval:
2007
UNII:
4MG6O8991R
Molecule Type:
Small molecule
Molecular Formula:
C30H47NO4S
Molecular Weight:
517.78
AlogP:
5.25
PSA:
66.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
RALTEGRAVIR
(2007)
Small molecule
Unknown
ORAL
Approved
Virus Diseases
RALTEGRAVIR
×
Maximum Phase:
4
First Approval:
2007
UNII:
22VKV8053U
Molecule Type:
Small molecule
Molecular Formula:
C20H21FN6O5
Molecular Weight:
444.42
AlogP:
0.91
PSA:
152.24
HBD:
3.0
HBA:
#RotB:
6.0
Source:
AMMONIA SOLUTION, STRONG
(2007)
Small molecule
Unknown
Unknown
Approved
Unknown
AMMONIA SOLUTION, STRONG
×
Maximum Phase:
4
First Approval:
2007
UNII:
5138Q19F1X
Molecule Type:
Small molecule
Molecular Formula:
H3N
Molecular Weight:
17.03
AlogP:
0.16
PSA:
35.0
HBD:
1.0
HBA:
#RotB:
0.0
Source:
SEVELAMER CARBONATE
(2007)
Small molecule
Unknown
ORAL
Approved
Renal Insufficiency, Chronic
SEVELAMER CARBONATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
9YCX42I8IU
Molecule Type:
Small molecule
Molecular Formula:
C7H14ClNO4
Molecular Weight:
211.65
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
LAPATINIB DITOSYLATE
(2007)
Small molecule
Epidermal growth factor receptor erbB1 inhibitor
ORAL
Approved
Breast Neoplasms
LAPATINIB DITOSYLATE
×
Maximum Phase:
4
First Approval:
2007
UNII:
G873GX646R
Molecule Type:
Small molecule
Molecular Formula:
C43H44ClFN4O11S3
Molecular Weight:
943.49
AlogP:
6.14
PSA:
106.35
HBD:
2.0
HBA:
#RotB:
11.0
Source:
1
2
…
56
57
58
59
60
61
62
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA